| Year |
Citation |
Score |
| 2022 |
Li X, Liu H, Dun MD, Faulkner S, Liu X, Jiang CC, Hondermarck H. Proteome and secretome analysis of pancreatic cancer cells. Proteomics. e2100320. PMID 35388624 DOI: 10.1002/pmic.202100320 |
0.41 |
|
| 2021 |
Yuan X, Zhang AZ, Ren YL, Wang XL, Jiang CH, Yang L, Liu CX, Liang WH, Pang LJ, Gu WY, Li F, Hu JM. Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis. Medicine. 100: e24519. PMID 33787569 DOI: 10.1097/MD.0000000000024519 |
0.302 |
|
| 2020 |
Ferdoushi A, Li X, Griffin N, Faulkner S, Jamaluddin MFB, Gao F, Jiang CC, van Helden DF, Tanwar PS, Jobling P, Hondermarck H. Schwann Cell Stimulation of Pancreatic Cancer Cells: A Proteomic Analysis. Frontiers in Oncology. 10: 1601. PMID 32984024 DOI: 10.3389/Fonc.2020.01601 |
0.371 |
|
| 2020 |
Gao F, Griffin N, Faulkner S, Li X, King SJ, Jobling P, Denham JW, Jiang CC, Hondermarck H. The membrane protein sortilin can be targeted to inhibit pancreatic cancer cell invasion. The American Journal of Pathology. PMID 32526166 DOI: 10.1016/J.Ajpath.2020.05.018 |
0.325 |
|
| 2020 |
Luo Y, Jiang C, Yu L, Yang A. Chemical Biology of Autophagy-Related Proteins With Posttranslational Modifications: From Chemical Synthesis to Biological Applications. Frontiers in Chemistry. 8: 233. PMID 32309274 DOI: 10.3389/fchem.2020.00233 |
0.33 |
|
| 2020 |
Liu H, Li X, Dun MD, Faulkner S, Jiang CC, Hondermarck H. Cold Shock Domain Containing E1 (CSDE1) Protein is Overexpressed and can be Targeted to Inhibit Invasiveness in Pancreatic Cancer Cells. Proteomics. e1900331. PMID 32170829 DOI: 10.1002/pmic.201900331 |
0.34 |
|
| 2017 |
Wang CY, Guo ST, Croft A, Yan XG, Jin L, Zhang XD, Jiang CC. BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922. Molecular Carcinogenesis. PMID 29068469 DOI: 10.1002/mc.22755 |
0.323 |
|
| 2017 |
Croft A, Guo ST, Sherwin S, Farrelly M, Yan XG, Zhang XD, Jiang CC. Functional identification of a novel transcript variant of INPP4B in human colon and breast cancer cells. Biochemical and Biophysical Research Communications. PMID 28189677 DOI: 10.1016/j.bbrc.2017.02.012 |
0.317 |
|
| 2016 |
Wang CY, Guo ST, Wang JY, Yan XG, Farrelly M, Zhang YY, Liu F, Yari H, La T, Lei FX, Jin L, Zhang XD, Jiang CC. Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922. Oncotarget. PMID 27391062 DOI: 10.18632/oncotarget.10414 |
0.338 |
|
| 2015 |
Liu XY, Lai F, Yan XG, Jiang CC, Guo ST, Wang CY, Croft A, Tseng HY, Wilmott JS, Scolyer RA, Jin L, Zhang XD. RIP1 Kinase Is an Oncogenic Driver in Melanoma. Cancer Research. 75: 1736-48. PMID 25724678 DOI: 10.1158/0008-5472.CAN-14-2199 |
0.32 |
|
| 2015 |
Tay KH, Liu X, Chi M, Jin L, Jiang CC, Guo ST, Verrills NM, Tseng HY, Zhang XD. Involvement of vacuolar H(+ -ATPase in killing of human melanoma cells by the sphingosine kinase analogue FTY720. Pigment Cell & Melanoma Research. 28: 171-83. PMID 25358761 DOI: 10.1111/pcmr.12326 |
0.329 |
|
| 2014 |
Liu YL, Lai F, Wilmott JS, Yan XG, Liu XY, Luan Q, Guo ST, Jiang CC, Tseng HY, Scolyer RA, Jin L, Zhang XD. Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells. Oncotarget. 5: 11237-51. PMID 25365078 |
0.304 |
|
| 2013 |
Wroblewski D, Jiang CC, Croft A, Farrelly ML, Zhang XD, Hersey P. OBATOCLAX and ABT-737 induce ER stress responses in human melanoma cells that limit induction of apoptosis Plos One. 8. PMID 24367627 DOI: 10.1371/journal.pone.0084073 |
0.302 |
|
| 2013 |
Wang XX, Ying P, Diao F, Wang Q, Ye D, Jiang C, Shen N, Xu N, Chen WB, Lai SS, Jiang S, Miao XL, Feng J, Tao WW, Zhao NW, et al. Altered protein prenylation in Sertoli cells is associated with adult infertility resulting from childhood mumps infection. The Journal of Experimental Medicine. 210: 1559-74. PMID 23825187 DOI: 10.1084/Jem.20121806 |
0.301 |
|
| 2005 |
Gau CL, Kato-Stankiewicz J, Jiang C, Miyamoto S, Guo L, Tamanoi F. Farnesyltransferase inhibitors reverse altered growth and distribution of actin filaments in Tsc-deficient cells via inhibition of both rapamycin-sensitive and -insensitive pathways. Molecular Cancer Therapeutics. 4: 918-26. PMID 15956249 DOI: 10.1158/1535-7163.Mct-04-0347 |
0.584 |
|
| 2004 |
Kho Y, Kim SC, Jiang C, Barma D, Kwon SW, Cheng J, Jaunbergs J, Weinbaum C, Tamanoi F, Falck J, Zhao Y. A tagging-via-substrate technology for detection and proteomics of farnesylated proteins. Proceedings of the National Academy of Sciences of the United States of America. 101: 12479-84. PMID 15308774 DOI: 10.1073/Pnas.0403413101 |
0.61 |
|
| 2001 |
Tamanoi F, Kato-Stankiewicz J, Jiang C, Machado I, Thapar N. Farnesylated proteins and cell cycle progression. Journal of Cellular Biochemistry. Supplement. 64-70. PMID 11842430 DOI: 10.1002/Jcb.10067 |
0.714 |
|
| 2001 |
Tamanoi F, Gau CL, Jiang C, Edamatsu H, Kato-Stankiewicz J. Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cells. Cellular and Molecular Life Sciences : Cmls. 58: 1636-49. PMID 11706990 DOI: 10.1007/Pl00000802 |
0.714 |
|
| 2001 |
Jiang C, Kato-Stankiewicz J, Gau C, Tamanoi F. Effects of farnesyltransferase inhibitors on cell cycle progression of human cancer cells Gene Function & Disease. 2: 99-107. DOI: 10.1002/1438-826X(200110)2:2/3<99::Aid-Gnfd99>3.0.Co;2-V |
0.42 |
|
| Show low-probability matches. |